Get started
Author

William K Gerber

Observed name: William K. Gerber
ORCID: 0009-0006-8103-0376
Observed ORCID: 0009-0006-8103-0376
OpenAlex ID: A5031781249
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
2023 · Shyam A. Patel, Jan Cerny, et al. · eJHaem · 25
PDF
Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid Tumors
2025 · William K. Gerber, Yiyu Xie, et al. · JCO Precision Oncology · 16
PDF
Natural history of clonal haematopoiesis seen in real‐world haematology settings
2024 · Shyam A. Patel, William K. Gerber, et al. · British Journal of Haematology · 16
PDF
Ontogeny and Natural History of Therapy‐Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic
2026 · Shyam A. Patel, Valerie Zhu, et al. · American Journal of Hematology · 2
Sole DNMT3A/TET2/ASXL1 Mutations Define a Distinct Clinical Trajectory for Patients with Clonal Hematopoiesis
2023 · Shyam Ajay Patel, William K Gerber, et al. · Blood · 2
PDF
Impaired Clearance of DNMT3A/TET2/ASXL1-Mutant Clones with Hypomethylating Agent or Intensive Induction Chemotherapy for Myelodysplastic Syndrome and Acute Myeloid Leukemia
2022 · Shyam A Patel, William K Gerber, et al. · Blood · 1
Clonal Dynamics and Deterministic Clinical Fate Mapping of Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukemia with TP53 Disruption
2023 · Shyam Ajay Patel, Benjamin Tanenbaum, et al. · Blood
Natural History of Patients with Clonal Hematopoiesis Seen in Hematology Clinics
2022 · Shyam A Patel, William K Gerber, et al. · Blood
Prognostic Discrimination within a Heterogeneous Population of TP53-Aberrant Myelodysplastic Syndromes and Acute Myeloid Leukemia
2022 · Shyam A Patel, Jan Cerny, et al. · Blood
Works count: 9
Citation count: 62
H-index: 3
I10-index: 3
Year
Topic
Type